Intravenous Nutrition/Vitamin and Mineral Injections
Reserved for those health issues requiring faster results, intravenous nutrition is a reliable method of increasing tissue levels of nutrition many times higher than nutrients by mouth could ever achieve. IV and IM nutrition allow for quickly "catching up" with nutritional deficiencies and are eventually discontinued: allowing foods and oral supplements to work best. Dr. Wald is the author of the most complete textbook on the subject of intravenous nutrition available. Because of age, illness, or medications, some people require higher-than-normal doses of nutrients or cannot absorb the nutrients they need from food alone. When vitamins and minerals are administered intravenously or with intramuscular injections, nutrients are absorbed rapidly into the bloodstream for delivery to the organs and tissues in need. These methods, in combination with a balanced, individually tailored diet and nutritional supplements (if needed), can meet one's nutritional needs more quickly and thoroughly than dietary interventions alone. WHAT YOU MUST KNOW – Our facility bases intravenous nutrition formula’s upon your health issues, your current stresses, your genetics and your laboratory work…as well as other factors. We DO NOT give every patient the same nutritional formula in their IV-drips; in fact, it is not uncommon for us to continuously change and adapt your IV-drip based on your progress, new research and your clinical response. This level of attention to your needs is what you will get and deserve!
Intravenous Vitamin C (IVC) IVC is almost completely ignored by mainstream medicine in spite of reasonable scientific evidence of its safety and usefulness. Consult the scientific references below for scientific support of IVC for a variety of serious medical conditions including cancer, heart disease, diabetes and other degenerative and inflammatory conditions.
Dr. Michael Wald is the author of the most comprehensive book on nutritional intravenous protocols available in the United States and abroad.
http://www.ncbi.nlm.nih.gov/pubmed/20511723 - Intravenous vitamin C kills cancer cells by producing hydrogen peroxide.
http://www.ncbi.nlm.nih.gov/pubmed/20424557 - Intravenous vitamin C for the treatment of herpetic neuralgia.
http://www.ncbi.nlm.nih.gov/pubmed/20400857 - Intravenous vitamin C reaches much higher blood levels than oral vitamin C could ever reach.
http://www.ncbi.nlm.nih.gov/pubmed/20171954 - In vivo experiment, intravenous administration of ascorbic acid significantly decreased the growth rate of mesothelioma tumor inoculated in mice. These data suggest that ascorbic acid may have benefits for patients with mesothelioma.
http://www.ncbi.nlm.nih.gov/pubmed/20170881 - Impaired microcirculatory reperfusion is improved by vitamin C infusion suggesting that oxidative stress is implicated
http://www.ncbi.nlm.nih.gov/pubmed/20150992 - Conclude that the inhibition of angiogenesis by ascorbate suggested in vitro is confirmed in vivo, and that angiogenesis inhibition may be one mechanism by which intravenous ascorbate therapy shows efficacy in animal experiments and clinical case studies.
http://www.ncbi.nlm.nih.gov/pubmed/19731754 - High dose intravenous vitamin C therapy may have benefits in patients with advanced cancers, and cancers with poor prognosis and limited therapeutic options, but further clinical studies regarding the safety and efficacy of this therapy are necessary, especially in Germany.
http://www.ncbi.nlm.nih.gov/pubmed/16567755 - “Early clinical studies showed that high-dose vitamin C, given by intravenous and oral routes, may improve symptoms and prolong life in patients with terminal cancer”.
http://www.ncbi.nlm.nih.gov/pubmed/18450228 - “This review describes the current state-of-the-art in oral and intravenous vitamin C pharmacokinetics. In addition, the governmental recommendations of dose and frequency of vitamin C intake will also be addressed”.
http://www.ncbi.nlm.nih.gov/pubmed/17053422 - Supraphysiological levels of ascorbate, which can only be achieved by the parenteral and not by the oral administration of vitamin C, may facilitate the restoration of vascular function in the critically ill patient.
http://www.ncbi.nlm.nih.gov/pubmed/19284416 - (For Acute Myeloid Leukemia) - The clinical benefit, along with a conspicuous absence of significant adverse events, suggests that further testing of LAA depletion alternating with pharmacologic dose intravenous supplementation in patients with these and other malignancies is warranted.
http://www.ncbi.nlm.nih.gov/pubmed/12410623 - Research into Intravenous Myer’s Coctail.
http://www.ncbi.nlm.nih.gov/pubmed/18468413 - Interstitial pneumonia can be controlled by the combined use of a prophylactic antibiotic system and the drip infusion system including megadose vitamin C.
http://www.ncbi.nlm.nih.gov/pubmed/19246295 - Intravenous administration of 2.83 g/kg vitamin C can promote the necrosis and apoptosis of hepatoma Walker256 cells in rats and protect the liver function of the tumor-bearing rats.
http://www.ncbi.nlm.nih.gov/pubmed/19154961 - High dosages of vitamin C will not increase stones in a person with normal kidney function.
http://www.ncbi.nlm.nih.gov/pubmed/19414313 - Intravenous vitamin C helps advanced cancers.
http://www.ncbi.nlm.nih.gov/pubmed/18974579 - Vitamin C helps hemodialysis patients.
http://www.ncbi.nlm.nih.gov/pubmed/12803508 - Intravenous vitamin C helps remove excessive bound iron.
http://www.ncbi.nlm.nih.gov/pubmed/18938145 - Intravenous vitamin C can kill cancer cells.
http://www.ncbi.nlm.nih.gov/pubmed/18830869 - Intravenous vitamin C helps hyperpigmentation.
http://www.ncbi.nlm.nih.gov/pubmed/18705014 - Intravenous vitamin C
http://www.ncbi.nlm.nih.gov/pubmed/18678913 - “These data suggest that ascorbate as a prodrug may have benefits in cancers with poor prognosis and limited therapeutic options”.
http://www.ncbi.nlm.nih.gov/pubmed/17502596 - “By using the synthesized probe peroxyxanthone, H(2)O(2) in extracellular fluid was detected only after parenteral administration of ascorbate and when Asc(*-) concentrations in extracellular fluid exceeded 100 nM. The data show that pharmacologic ascorbate is a prodrug for preferential steady-state formation of Asc(*-) and H(2)O(2) in the extracellular space but not blood”.
http://www.ncbi.nlm.nih.gov/pubmed/16157892 - “Findings give plausibility to i.v. ascorbic acid in cancer treatment, and have unexpected implications for treatment of infections where H(2)O(2) may be beneficial.”
http://www.ncbi.nlm.nih.gov/pubmed/20068072 - These results show that pharmacologic doses of ascorbate, easily achievable in humans, may have potential for therapy in pancreatic cancer.
http://www.ncbi.nlm.nih.gov/pubmed/18544557 - “High-dose i.v. ascorbic acid was well tolerated but failed to demonstrate anticancer activity when administered to patients with previously treated advanced malignancies. The promise of this approach may lie in combination with cytotoxic or other redox-active molecules”.
http://www.ncbi.nlm.nih.gov/pubmed/19414313 - High Dose vitamin C in advanced cancer.
http://www.ncbi.nlm.nih.gov/pubmed/12013679 - Cancer and intravenous vitamin C.
http://www.ncbi.nlm.nih.gov/pubmed/18450228 - The significance of intravenous vitamin C administration.
http://www.ncbi.nlm.nih.gov/pubmed/17965239 - Results support the hypothesis that oxidative stress plays a major role in the reduced resting whole leg blood flow and increased leg vasoconstriction observed with aging in men.
http://www.ncbi.nlm.nih.gov/pubmed/17892985 - Vitamin C improves heart function.
http://www.ncbi.nlm.nih.gov/pubmed/17297243 - Vitamin C is considered a safe and effective therapy to improve the quality of life of terminal cancer patients.
http://www.ncbi.nlm.nih.gov/pubmed/16116933 - Ascorbate concentrations sufficient to kill tumor cells can be safely achieved in solid tumors in vivo, suggesting a possible role for high dose intravenous ascorbate in treating cancer.
http://www.ncbi.nlm.nih.gov/pubmed/15806791 - Vitamin C can kill cancer cells and may also assist chemotherapy.
